Study to Assess the Safety and Tolerability of Single Doses of REGN1500

NCT01749878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: REGN1500
DRUG: placebo

Sponsor

Regeneron Pharmaceuticals